Related Attorneys
We represented Watson in this Hatch-Waxman patent litigation involving Watson’s ANDA for a generic version of Takeda’s Colcrys® colchicine tablets. Takeda asserted 17 patents covering several uses of colchicine. The case is currently stayed pending FTC approval of settlement. District of Delaware (2014-2015).